Recent changes in endometrial cancer trends among menopausal-age US women

Paige Wartko, Mark E. Sherman, Hannah P. Yang, Ashley S. Felix, Louise A. Brinton, Britton Trabert

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background: Changes in endometrial cancer incidence rates after the precipitous decline in menopausal hormone therapy (MHT) use in 2002 have not been evaluated. Methods: Using data from the Surveillance, Epidemiology, and End Results Program from 1992 to 2009 (SEER 13), we identified 63. 428 incident endometrial cancer cases among women ages 20-74. We compared annual percent change (APC) in endometrial cancer incidence rates from 1992 to 2002 to rates from 2003 to 2009. Results: In contrast to the constant endometrial cancer rate pattern observed from 1992 to 2002 (APC 0.0%), rates increased after 2002 in women 50-74 years old (2.5%; PAPC comparison<0.01). Endometrial cancer incidence increased over the entire time period among women ages 20-49 (1992-2002: 1.1%; 2003-2009: 2.1%; PAPC comparison=0.21). Post-2002 increases in incidence among women ages 50-74 were specific to Type I endometrial tumors (1992-2002: -0.6%; 2003-2009: 1.6%; PAPC comparison<0.01). Discussion: The increase in endometrial cancer incidence rates after 2002 may be related to the widespread decrease in estrogen plus progestin MHT use, which has been reported to lower endometrial cancer risk in overweight and obese women.

Original languageEnglish (US)
Pages (from-to)374-377
Number of pages4
JournalCancer Epidemiology
Volume37
Issue number4
DOIs
StatePublished - Aug 2013

Fingerprint

Endometrial Neoplasms
Incidence
Hormones
SEER Program
Progestins
Estrogens
Therapeutics
Neoplasms

Keywords

  • Endometrial cancer
  • Incidence
  • Menopausal hormone therapy
  • Menopausal-age women
  • Trends

ASJC Scopus subject areas

  • Epidemiology
  • Oncology
  • Cancer Research

Cite this

Recent changes in endometrial cancer trends among menopausal-age US women. / Wartko, Paige; Sherman, Mark E.; Yang, Hannah P.; Felix, Ashley S.; Brinton, Louise A.; Trabert, Britton.

In: Cancer Epidemiology, Vol. 37, No. 4, 08.2013, p. 374-377.

Research output: Contribution to journalArticle

Wartko, Paige ; Sherman, Mark E. ; Yang, Hannah P. ; Felix, Ashley S. ; Brinton, Louise A. ; Trabert, Britton. / Recent changes in endometrial cancer trends among menopausal-age US women. In: Cancer Epidemiology. 2013 ; Vol. 37, No. 4. pp. 374-377.
@article{80f6a4e717db4b2fbffa178fbde7a357,
title = "Recent changes in endometrial cancer trends among menopausal-age US women",
abstract = "Background: Changes in endometrial cancer incidence rates after the precipitous decline in menopausal hormone therapy (MHT) use in 2002 have not been evaluated. Methods: Using data from the Surveillance, Epidemiology, and End Results Program from 1992 to 2009 (SEER 13), we identified 63. 428 incident endometrial cancer cases among women ages 20-74. We compared annual percent change (APC) in endometrial cancer incidence rates from 1992 to 2002 to rates from 2003 to 2009. Results: In contrast to the constant endometrial cancer rate pattern observed from 1992 to 2002 (APC 0.0{\%}), rates increased after 2002 in women 50-74 years old (2.5{\%}; PAPC comparison<0.01). Endometrial cancer incidence increased over the entire time period among women ages 20-49 (1992-2002: 1.1{\%}; 2003-2009: 2.1{\%}; PAPC comparison=0.21). Post-2002 increases in incidence among women ages 50-74 were specific to Type I endometrial tumors (1992-2002: -0.6{\%}; 2003-2009: 1.6{\%}; PAPC comparison<0.01). Discussion: The increase in endometrial cancer incidence rates after 2002 may be related to the widespread decrease in estrogen plus progestin MHT use, which has been reported to lower endometrial cancer risk in overweight and obese women.",
keywords = "Endometrial cancer, Incidence, Menopausal hormone therapy, Menopausal-age women, Trends",
author = "Paige Wartko and Sherman, {Mark E.} and Yang, {Hannah P.} and Felix, {Ashley S.} and Brinton, {Louise A.} and Britton Trabert",
year = "2013",
month = "8",
doi = "10.1016/j.canep.2013.03.008",
language = "English (US)",
volume = "37",
pages = "374--377",
journal = "Cancer Epidemiology",
issn = "1877-7821",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Recent changes in endometrial cancer trends among menopausal-age US women

AU - Wartko, Paige

AU - Sherman, Mark E.

AU - Yang, Hannah P.

AU - Felix, Ashley S.

AU - Brinton, Louise A.

AU - Trabert, Britton

PY - 2013/8

Y1 - 2013/8

N2 - Background: Changes in endometrial cancer incidence rates after the precipitous decline in menopausal hormone therapy (MHT) use in 2002 have not been evaluated. Methods: Using data from the Surveillance, Epidemiology, and End Results Program from 1992 to 2009 (SEER 13), we identified 63. 428 incident endometrial cancer cases among women ages 20-74. We compared annual percent change (APC) in endometrial cancer incidence rates from 1992 to 2002 to rates from 2003 to 2009. Results: In contrast to the constant endometrial cancer rate pattern observed from 1992 to 2002 (APC 0.0%), rates increased after 2002 in women 50-74 years old (2.5%; PAPC comparison<0.01). Endometrial cancer incidence increased over the entire time period among women ages 20-49 (1992-2002: 1.1%; 2003-2009: 2.1%; PAPC comparison=0.21). Post-2002 increases in incidence among women ages 50-74 were specific to Type I endometrial tumors (1992-2002: -0.6%; 2003-2009: 1.6%; PAPC comparison<0.01). Discussion: The increase in endometrial cancer incidence rates after 2002 may be related to the widespread decrease in estrogen plus progestin MHT use, which has been reported to lower endometrial cancer risk in overweight and obese women.

AB - Background: Changes in endometrial cancer incidence rates after the precipitous decline in menopausal hormone therapy (MHT) use in 2002 have not been evaluated. Methods: Using data from the Surveillance, Epidemiology, and End Results Program from 1992 to 2009 (SEER 13), we identified 63. 428 incident endometrial cancer cases among women ages 20-74. We compared annual percent change (APC) in endometrial cancer incidence rates from 1992 to 2002 to rates from 2003 to 2009. Results: In contrast to the constant endometrial cancer rate pattern observed from 1992 to 2002 (APC 0.0%), rates increased after 2002 in women 50-74 years old (2.5%; PAPC comparison<0.01). Endometrial cancer incidence increased over the entire time period among women ages 20-49 (1992-2002: 1.1%; 2003-2009: 2.1%; PAPC comparison=0.21). Post-2002 increases in incidence among women ages 50-74 were specific to Type I endometrial tumors (1992-2002: -0.6%; 2003-2009: 1.6%; PAPC comparison<0.01). Discussion: The increase in endometrial cancer incidence rates after 2002 may be related to the widespread decrease in estrogen plus progestin MHT use, which has been reported to lower endometrial cancer risk in overweight and obese women.

KW - Endometrial cancer

KW - Incidence

KW - Menopausal hormone therapy

KW - Menopausal-age women

KW - Trends

UR - http://www.scopus.com/inward/record.url?scp=84878937149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878937149&partnerID=8YFLogxK

U2 - 10.1016/j.canep.2013.03.008

DO - 10.1016/j.canep.2013.03.008

M3 - Article

C2 - 23591011

AN - SCOPUS:84878937149

VL - 37

SP - 374

EP - 377

JO - Cancer Epidemiology

JF - Cancer Epidemiology

SN - 1877-7821

IS - 4

ER -